GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Corp (STU:MCK) » Definitions » Capital Expenditure

McKesson (STU:MCK) Capital Expenditure : €-740.26 Mil (TTM As of Sep. 2024)


View and export this data going back to 1987. Start your Free Trial

What is McKesson Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

McKesson's cash flow for capital expenditures for the three months ended in Sep. 2024 was €-196 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2024 was €-740.26 Mil.

McKesson Capital Expenditure Historical Data

The historical data trend for McKesson's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Capital Expenditure Chart

McKesson Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -457.93 -538.44 -485.78 -521.17 -632.04

McKesson Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -131.18 -141.22 -247.48 -155.14 -196.42

McKesson Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-740.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

McKesson Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Corp (STU:MCK) » Definitions » Capital Expenditure
Comparable Companies
COR CAH HSIC PDCO OMI ZYXI AHG EDAP YI COSM SHSE:601607 HKSE:01099 SHSE:600332 MIL:AMP XSWX:GALE NZSE:EBO SHSE:600511 TSE:7459 TSE:2784 ASX:SIG
Traded in Other Exchanges
MCK:USA MCK:Mexico 0JZU:UK MCK:Germany M1CK34:Brazil
Address
6555 State Highway 161, Irving, TX, USA, 75039
Website
https://www.mckesson.com
McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.